Issued Patents All Time
Showing 1–25 of 59 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428487 | Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2025-09-30 |
| 12403203 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2025-09-02 |
| 12397062 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2025-08-26 |
| 12370264 | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2025-07-29 |
| 12357703 | Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping | Romesh R. Subramanian, Mohammed T. Qatanani | 2025-07-15 |
| 12329824 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2025-06-17 |
| 12329825 | Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject | Romesh R. Subramanian, Mohammed T. Qatanani | 2025-06-17 |
| 12325753 | Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy | Romesh R. Subramanian, Mohammed T. Qatanani | 2025-06-10 |
| 12319743 | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2025-06-03 |
| 12280122 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2025-04-22 |
| 12263225 | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy | Romesh R. Subramanian, Mohammed T. Qatanani | 2025-04-01 |
| 12239716 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2025-03-04 |
| 12239717 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2025-03-04 |
| 12173079 | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide | Romesh R. Subramanian, Mohammed T. Qatanani | 2024-12-24 |
| 12173078 | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2024-12-24 |
| 12150938 | Biomarker of polycystic kidney disease and uses thereof | Nikolai Bukanov, Sarah Moreno | 2024-11-26 |
| 12144868 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2024-11-19 |
| 12144867 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2024-11-19 |
| 12128109 | Muscle targeting complexes and formulations for treating dystrophinopathies | Scott A. Hilderbrand, Sean Spring, Peiyi Shen, Cody A. Desjardins, Romesh R. Subramanian +3 more | 2024-10-29 |
| 12102687 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2024-10-01 |
| 12097263 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2024-09-24 |
| 12018087 | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins | 2024-06-25 |
| 12012460 | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide | Romesh R. Subramanian, Mohammed T. Qatanani | 2024-06-18 |
| 12005124 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani | 2024-06-11 |
| 11986537 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Romesh R. Subramanian, Mohammed T. Qatanani, Cody A. Desjardins, Brendan Quinn, John Najim | 2024-05-21 |